These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27921315)

  • 1. Imputing estrogen receptor (ER) status in a population-based cancer registry: a sensitivity analysis.
    Andridge R; Noone AM; Howlader N
    Stat Med; 2017 Mar; 36(6):1014-1028. PubMed ID: 27921315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.
    Howlader N; Noone AM; Yu M; Cronin KA
    Am J Epidemiol; 2012 Aug; 176(4):347-56. PubMed ID: 22842721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.
    Anderson WF; Luo S; Chatterjee N; Rosenberg PS; Matsuno RK; Goodman MT; Hernandez BY; Reichman M; Dolled-Filhart MP; O'Regan RM; Garcia-Closas M; Perou CM; Jatoi I; Cartun RW; Sherman ME
    Breast Cancer Res Treat; 2009 Jan; 113(1):189-96. PubMed ID: 18256926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of breast cancer in the United States: current and future trends.
    Anderson WF; Katki HA; Rosenberg PS
    J Natl Cancer Inst; 2011 Sep; 103(18):1397-402. PubMed ID: 21753181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.
    Anderson WF; Chen BE; Jatoi I; Rosenberg PS
    Breast Cancer Res Treat; 2006 Nov; 100(1):121-6. PubMed ID: 16685588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of missing data on reported breast cancer mortality.
    Plichta JK; Rushing CN; Lewis HC; Rooney MM; Blazer DG; Thomas SM; Hwang ES; Greenup RA
    Breast Cancer Res Treat; 2023 Jan; 197(1):177-187. PubMed ID: 36334190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status.
    Park JH; Anderson WF; Gail MH
    J Clin Oncol; 2015 Sep; 33(26):2870-6. PubMed ID: 26195709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater absolute risk for all subtypes of breast cancer in the US than Malaysia.
    Horne HN; Beena Devi CR; Sung H; Tang TS; Rosenberg PS; Hewitt SM; Sherman ME; Anderson WF; Yang XR
    Breast Cancer Res Treat; 2015 Jan; 149(1):285-91. PubMed ID: 25537643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.
    Mezencev R; Švajdler M
    Breast Cancer; 2017 May; 24(3):400-410. PubMed ID: 27502779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.
    Silva A; Rauscher GH; Ferrans CE; Hoskins K; Rao R
    J Registry Manag; 2014; 41(1):24-30. PubMed ID: 24893185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing not at random in end of life care studies: multiple imputation and sensitivity analysis on data from the ACTION study.
    Carreras G; Miccinesi G; Wilcock A; Preston N; Nieboer D; Deliens L; Groenvold M; Lunder U; van der Heide A; Baccini M;
    BMC Med Res Methodol; 2021 Jan; 21(1):13. PubMed ID: 33422019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imputation of missing values of tumour stage in population-based cancer registration.
    Eisemann N; Waldmann A; Katalinic A
    BMC Med Res Methodol; 2011 Sep; 11():129. PubMed ID: 21929796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models.
    Pham TM; Carpenter JR; Morris TP; Wood AM; Petersen I
    Stat Med; 2019 Feb; 38(5):792-808. PubMed ID: 30328123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What impact do assumptions about missing data have on conclusions? A practical sensitivity analysis for a cancer survival registry.
    Smuk M; Carpenter JR; Morris TP
    BMC Med Res Methodol; 2017 Feb; 17(1):21. PubMed ID: 28166735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a weighting approach for performing sensitivity analysis after multiple imputation.
    Rezvan PH; White IR; Lee KJ; Carlin JB; Simpson JA
    BMC Med Res Methodol; 2015 Oct; 15():83. PubMed ID: 26464305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.
    Anderson WF; Chu KC; Chatterjee N; Brawley O; Brinton LA
    J Clin Oncol; 2001 Jan; 19(1):18-27. PubMed ID: 11134191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of Sensitivity to the Missing-at-Random Assumption Using Multiple Imputation With Delta Adjustment: Application to a Tuberculosis/HIV Prevalence Survey With Incomplete HIV-Status Data.
    Leacy FP; Floyd S; Yates TA; White IR
    Am J Epidemiol; 2017 Feb; 185(4):304-315. PubMed ID: 28073767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.